Good Distribution Practices

Distribution and Shipment e.g. Compliance with Good Distribution Practice... 

This means that Australia, Malaysia and Venezuela have to invest significant human and financial resources in inspections of the supply channels in their respective countries in order to ensure compliance with the requirements of good distribution practice (GDP) and the provisions of the pharmaceutical laws. Arranging human resources and schedules for inspection is even more arduous when the distribution outlets are widely dispersed through the rural areas. 

ACC and SOCMA each have programs to promote good practices among member companies in the area of chemical process safety. Similarly, NACD promotes good distribution practices and dissemination of information to end-use customers on the proper handling of chemical products. 

Heparin exposed the multi-layered nature of many supply chains and the high levels of manufacturer uncertainties that are present with regards to their raw materials supply base (Shanley et al., 2008). USP has also introduced a general chapter entitled Good Distribution Practices-Supply Chain Integrity <1083> to try and address these issues (USP, 2012a). 

In accordance with Article 10 of Council Directive 92/25/EEC, a guideline has been prepared on Good Distribution Practice of medicinal products... 

Ensure that all medicines manufacturing, importation, exportation, wholesale and distribution establishments are licensed. Activities and premises must comply with Good Manufacturing Practices (GMP) and Good Distribution Practice requirements... 

Taylor, J., Turner, J., and Munro, G. (1998), Good Manufacturing Practice and Good Distribution Practice An Analysis of Regulatory Inspection Eindings, The Pharmaceutical Journal, November 7, 1998. The Pharmaceutical Press, The Royal Pharmaceutical Society, London. 

Good Distribution Practice for Medicinal Products for Human Use 94/C 63/03, Official Journal of the European Communities L113, April 30, 1992. 

Good Distribution Practice (GDP) MHRA GDP is that part of quality assurance that ensures that products are consistently stored, transported, and handled under suitable conditions. 

In order to comply with Good Distribution Practice (GDP), all applicants are required to submit the documents listed below for our consideration ... 

The Committee was pleased to note the cooperation and collaboration between Policy, Access and Rational Use (PAR) and QSM. The Committee was informed about the usefulness of its work, i.e. in the preparation of guidelines, monographs and good distribution practices and was requested to expedite the deliberations. 

The Committee was provided with the background to the document on good distribution practices for pharmaceutical products and the comments received. After discussion of these comments, and appropriate amendments, the document was adopted (Annex 5). 

Good distribution practices (GDP) for pharmaceutical products (new, Armex 5). 

A distribution procedure to ensure that the oldest stock is distributed and/or used before a newer and identical stock item is distributed and/or used. good distribution practices (GDP)... 

Good distribution practices are that part of quality assurance that ensures that the quality of a pharmaceutical product is maintained by means of adequate control of the numerous activities which occur throughout the distribution process. 

Once the evaluation of a product dossier is complete, and the inspection has been performed to assess compliance with good manufacturing practices, good storage practices and good distribution practices as appropriate, the procurement agency should prepare a list reflecting the status of the prequalified products and manufacturers. 

Those operating at wholesale level must similarly hold an appropriate authorisation and are also subject to inspection to ensure that they are operating in accordance with legal requirements, including good distribution practice ( GDP ) rules established under Directive 92/25/EEC. Specified paperwork and records must be kept (in particular to facilitate tracing of product and batch recall) and proper systems and operating procedures adhered to. 

A new block of directives gives details on practical aspects for the rational use of medicinal products. Directive 92/25/EEC concerns the distribution from the producer to the dispenser. According to this directive, distribution of medicinal products must be in accordance with good distribution practice (GDP) only approved products may be distributed, and may be delivered exclusively to persons authorized for supplying the public in the concerned country. 

The staff shall be provided with knowledge about the principles and guidelines of good distribution practice. 

---